4
Changes in Ownership
Evommune, Inc. Filed Acc 0002092017-26-000007
Chief Scientific Officer sold 1,488 shares at $22.50 ($33,480)
- Chief Scientific Officer acquired 1,488 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Jeegar Pravinkumar Chief Scientific Officer | 2026-06-22 | Option exercise 10b5-1 | +1,488 | $3.84 | $5,714 | 47,891 | D |
| Patel Jeegar Pravinkumar Chief Scientific Officer | 2026-06-22 | Sale 10b5-1 | −1,488 | $22.50 | $33,480 | 46,403 | D |
| Derivatives | |||||||
| Patel Jeegar Pravinkumar Chief Scientific Officer | 2026-06-22 | Option exercise · Employee Stock Option (Right to Buy) 10b5-1 | −1,488 | 27,842 | D | ||
| Open-market sales · 1,488 sh · avg $22.50 · $33,480 | |||||||
Loading xslF345X06/primarydocument.xml…